about
Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabul...
Read More
2.59
0.04
(1.57%)
163.2K
XNAS Volume
XNAS 21 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
Veru Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..